Regeneron Makes History: FDA Approves Otarmeni, the First Gene Therapy for Rare Genetic Hearing Loss NEW YORK — In a landmark victory for precision medicine, the U.S. Food and Drug Administration (FDA) has granted approval to Regeneron Pharmaceuticals’ Otarmeni, marking the first time a gene therapy for hearing loss has been cleared for clinical use. … Read more
The silent epidemic of hearing loss may have just revealed a critical new target for prevention and treatment. Groundbreaking research, presented at the upcoming Biophysical Society Annual Meeting, suggests that the proteins long understood to *receive* sound signals in the ear are also actively involved in maintaining the structural integrity of the cells themselves. When … Read more
Beyond Sound: How AI is Pioneering Personalized Success for Children with Cochlear Implants Nearly 32.5 million Americans experience some form of hearing loss, and for many children, cochlear implants offer a pathway to auditory access and language development. But the journey isn’t uniform. Predicting how well a child will learn to speak after implantation has … Read more